Six Senators Reintroduce Bipartisan Bill to Protect 340B Hospitals From COVID Fallout

Sen. John Thune (R-S.D.) his and his six Senate colleagues' bipartisan bill "would ensure that no hospital that is currently participating in the 340B program can lose eligibility due to a reduction in hospitalizations during the pandemic." | C-SPAN

A bipartisan group of six U.S. senators on Tuesday reintroduced legislation from the last session of Congress to protect hospitals from losing eligibility for 340B drug discounts during the COVID-19 pandemic.

Five of the six types of hospitals that can

Read More »

The Patient Journey: Are You Missing Something?

SPONSORED CONTENT

Do you provide clinical care for patients living with or at risk of HIV? If so, you know how important it is to consider their needs beyond the clinic visit.

The patient journey is not linear. Social stigma, family issues, mental health challenges, financial hardship,

Read More »

Sanders Holding Senate Hearing on Drug Prices Next Week

Sen. Bernie Sanders (I-Vt.) a Senate Democratic letter to PhRMA last September decrying drug companies' denials of and conditions on 340B contract pharmacy drugs. | C-SPAN

U.S. Sen. Bernie Sanders (I-Vt.) has scheduled a hearing next Tuesday of the U.S. Senate health subcommittee he chairs on why the United States pays the highest prices in the world for prescription drugs.

The Senate Health, Education, Labor, and

Read More »

Amazon Is Opening its Employees-only Primary and Urgent Care Service to Companies Nationwide

Amazon Care, the online retailer's expanded telehealth and home-visit health care service, includes “prescription delivery right to a patient’s door.” | Amazon

Online retailer Amazon announced yesterday that it began offering companies in Washington state access to its Amazon Care telehealth and home-visit primary and urgent health care services, which include “prescription delivery right to a patient’s door.”

Until now, Amazon

Read More »

Injunction in Lilly Case Could Cause HHS to Re-Issue 340B Dispute Resolution Rule

Drug manufacturer Eli Lilly said it is pleased with a court's injunction yesterday stopping 340B dispute resolution proceedings against it over its denials of 340B pricing on contract pharmacy drugs. | Shutterstock

A federal judge’s decision to temporarily shield drug manufacturer Eli Lilly from the 340B program’s administrative dispute resolution (ADR) process could cause the government to issue 340B ADR regulations all over again, health care attorneys say.

U.S. District Judge Sarah

Read More »

Breaking: Federal Judge Grants Lilly’s Motion to Halt 340B Dispute Resolution System

In a decision that could have significant implications for 340B stakeholders, a federal district judge in Indianapolis today granted drug manufacturer Eli Lilly’s motion for a preliminary injunction stopping the U.S. Health and Human Services Department from implementing or enforcing

Read More »

Opposition to Express Scripts’ 340B Claims ID Requirement Grows

U.S. Rep. Abigail Spanberger (D-Va.) said her successful amendment today to a spending bill sends big pharma the message "Stop hiking drug prices on consumers and discriminating against our 340B providers and pharmacies."

Correction, Tuesday March 16, 4:00 p.m. EDT—Earlier today, we reported that during a March 16 webinar, advisers to 340B covered entities said that U.S. Rep. Abigail Spanberger (D-Va.) had written to pharmacy benefit manager Express Scripts (ESI) about its new

Read More »

FQHCs Fiercely Oppose Trump’s 340B Insulin Pricing Rule in New Round of Comments

HRSA received 200 comments on the Biden administration's proposal to delay until July 20 the effective date of a controversial rule on how much health centers can charge low-income patients for insulin and injectable epinephrine.

Federally qualified health centers and their trade groups are adamantly opposed to implementing a Trump administration rule to require health centers to provide insulin and injectable epinephrine to low-income patients at the price the centers pay for those drugs under

Read More »

Medicare’s 340B Drug Reimbursement Cuts in 2019 Were Exacerbated by Change in Drugs’ Payment Status

A change in Medicare Part B payment status for "an unusually high" number of drugs in 2019 led to "substantially" lower payments to 340B hospitals, congressional Medicare advisers said this week.

Medicare Part B drug payments to 340B hospitals “declined substantially” in 2019 because the payment status of “an unusually high number of drugs” changed that year, congressional Medicare advisers said in a report yesterday.

The change—from “pass-through status” to “separately

Read More »

Biden Nominates Veteran Capitol Hill Aide to be HHS Assistant Secretary

Melanie Egorin, a veteran Democratic congressional health care adviser, has been tapped to be the next HHS Assistant Secretary for Legislation.

President Biden has nominated Melanie Egorin, a veteran Democratic congressional health care adviser, to serve as U.S. Health and Human Services (HHS) Assistant Secretary for Legislation.

If confirmed, Egorin would be a top deputy to Xavier Becerra, whose nomination to

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live